LLYEli Lilly
Eli Lilly and Company (referred to as the company, Lilly, we, or us) was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly. 10-K, Item 1
- Employees
- 50,000
- Headquarters
- Indianapolis, IN
- CEO
- David A. Ricks
- Next results
- around Feb 3, 2027
What changed
10-K filed Feb 12, 2026 against Feb 19, 2025| Area | What changed | Source |
|---|---|---|
| Risk factors | 9 new paragraphs, nothing like them in the previous 10-K | 10-K Item 1A |
| Receivables growing faster than revenue | Receivables +61.4% vs revenue +44.7% (+16.7 pts) | 10-K · XBRL |
| Cash from operations lower than net income | Cash from operations $16.8B vs net income $20.6B (FY ending 2025-12-31) | 10-K · XBRL |
| Inventory growing faster than revenue | Inventory +81.1% vs revenue +44.7% (+36.4 pts) | 10-K · XBRL |
| Accounting checks | 8 other checks clear, 3 worth a look | 10-K · XBRL |
| Insiders | No open-market buys in the last 90 days | Form 4 |
| Filings | 2 in the last 30 days | EDGAR |
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
What's new, in their words
10-K filed Feb 12, 2026Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-19. Quoted as filed.
In November 2025, we announced preliminary voluntary agreements with the U.S. government in which, among other arrangements, we agreed to implement measures to lower Medicaid and certain other drug prices for U.S. patients and to launch new medicines with a more balanced pricing approach across developed nations. We face risks and…
10-K, Item 1A
Accounting checks
latest 10-K8 of 11 clear 3 worth a look. Checks, not verdicts.
- !Receivables growing faster than revenueReceivables +61.4% vs revenue +44.7% (+16.7 pts)
- !Cash from operations lower than net incomeCash from operations $16.8B vs net income $20.6B (FY ending 2025-12-31)
- !Inventory growing faster than revenueInventory +81.1% vs revenue +44.7% (+36.4 pts)
- ✓Same auditor in both 10-Ks: Ernst & Young LLP
- ✓No statement of substantial doubt about going concern
- ✓No 8-K item 4.02 in the last 2 years
- ✓No NT 10-K or NT 10-Q in the last 2 years
- ✓The same matters as last year: Medicaid, Managed Care, and Medicare sales rebate accruals
- ✓No sentence in the 10-K concludes that controls were not effective because of a material weakness
- ✓No 8-K item 2.06 in the last 2 years
- ✓No 8-K item 1.03 in the last 2 years
In the last 30 days
All filings →- Oct 29, 20268-K Quarterly results 8-K item 2.02
- Oct 29, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q.
RSS feed
Work on LLY in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/LLY/export.csv") into a cell.